Tejada-Illa, C, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Rico, M, Vidal, N, Martin-Aguilar, L, Caballero-Avila, M, Lleixà, C, Collet-Vidiella, R, Llansó, L, Carbayo, A, Vesperinas, A, Querol, L, Pascual-Goñi, E. Digital biomechanical assessment of gait in patients with peripheral neuropathies. Journal of NeuroEngineering and Rehabilitation. 2025; 22(1)DOI:10.1186/s12984-025-01694-w. PMID:40653470. IF:5.200(Q1/1D).

Fonseca, EG, Olivé-Cirera, G, Chen, LW, Paredes-Carmona, F, Enamorado, NN, Duran, SB, Mendibe, MD, Visa-Reñe, N, Vázquez-López, M, Felipe-Rucián, A, Romeu, G, Martinez-Hernandez, E, Blanco, Y, Sepulveda, M, Saiz, A, Dalmau, J, Armangue, T. Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(4)DOI:10.1212/NXI.0000000000200400. PMID:40505071. IF:7.500(Q1/1D).

Caballero-Avila, M, Martin-Aguilar, L, Collet-Vidiella, R, Querol, L, Pascual-Goñi, E. A pathophysiological and mechanistic review of chronic inflammatory demyelinating polyradiculoneuropathy therapy. Frontiers in Immunology. 2025; 16DOI:10.3389/fimmu.2025.1575464. PMID:40297573. IF:5.900(Q1/2D).

Vidal-Jordana, A, Ontaneda, D. To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis. NEUROLOGY. 2025; 104(7)DOI:10.1212/WNL.0000000000213416. PMID:40036710. IF:8.500(Q1/1D).

Rodríguez-Jorge, F, Fernández-Velasco, JI, Villarrubia, N, Gracia-Gil, J, Fernández, E, Meca-Lallana, V, Díaz-Pérez, C, de la Maza, SS, Pacheco, EM, Quiroga, A, Ramió-Torrentà, L, Martínez-Yélamos, S, Bau, L, Monreal, E, López-Real, A, Rodero-Romero, A, Borrega, L, Díaz, S, Eguía, P, Espiño, M, Chico-García, JL, Barrero, FJ, Martínez-Ginés, ML, García-Domínguez, JM, de la Fuente, S, Moreno, I, Sainz-Amo, R, Mañé-Martínez, MA, Caminero, A, Castellanos-Pinedo, F, López, AG, Labiano-Fontcuberta, A, Ayuso, L, Abreu, R, Hernández, MA, Meca-Lallana, J, Martín-Aguilar, L, Garcia, AM, Masjuan, J, Costa-Frossard, L, Villar, LM. Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024). Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1535051. PMID:39749346. IF:5.900(Q1/2D).

Rodríguez-Jorge, F, Fernández-Velasco, JI, Villarrubia, N, Gracia-Gil, J, Fernández, E, Meca-Lallana, V, Díaz-Pérez, C, Sainz de la Maza, S, Pacheco, EM, Quiroga, A, Ramió-Torrentà, L, Martínez-Yélamos, S, Bau, L, Monreal, E, López-Real, A, Rodero-Romero, A, Borrega, L, Díaz, S, Eguía, P, Espiño, M, Chico-García, JL, Barrero, FJ, Martínez-Ginés, ML, García-Domínguez, JM, De la Fuente, S, Moreno, I, Sainz-Amo, R, Mañé-Martínez, MA, Caminero, A, Castellanos, F, Gómez López, A, Labiano-Fontcuberta, A, Ayuso, L, Abreu, R, Hernández, MA, Meca-Lallana, J, Martín-Aguilar, L, Muriel García, A, Masjuan, J, Costa-Frossard, L, Villar, LM. Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1480676. PMID:39606235. IF:5.900(Q1/2D).

Barrot, J, Caylà, JA, Mata-Cases, M, Real, J, Vlacho, B, Franch-Nadal, J, Mauricio, D. Machine learning models for the prediction of COVID-19 prognosis in the primary health care setting. Bmc Primary Care. 2025; 26(1)DOI:10.1186/s12875-025-02960-5. PMID:41087937. IF:2.600(Q1/1D).

Vlacho, B, Julve, J, Genua, I, Fernández-Camins, B, Real, J, Franch-Nadal, J, Mauricio, D, Ortega, E. Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry. Journal of Clinical Lipidology. 2025; 19(4)DOI:10.1016/j.jacl.2025.04.195. PMID:40467441. IF:4.600(Q1/2D).